|
|
|
|
|
Sponsors and Collaborators: |
University of California, San Francisco University of California Tobacco Related Disease Research Program |
Information provided by: | University of California, San Francisco |
ClinicalTrials.gov Identifier: | NCT00714532 |
This study aims at developing and testing a stage-based scheduled smoking intervention that targets to encourage smokers to reduce smoking and to facilitate smoking abstinence. We hypothesize that smokers who receive the staged-based scheduled smoking intervention will be more likely to report smoking abstinence, quit attempts, and smoking reduction at 12 months.
Condition | Intervention |
Smoking Cessation |
Behavioral: Expert System Only Behavioral: Enhanced Expert System |
MedlinePlus related topics: | Smoking Smoking Cessation |
ChemIDplus related topics: | Nicotine polacrilex Nicotine tartrate BaseLine |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment |
Official Title: | A Stage-Based Scheduled Smoking Intervention for Chinese |
Estimated Enrollment: | 400 |
Study Start Date: | April 2007 |
Estimated Study Completion Date: | June 2009 |
Estimated Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
1: Active Comparator
Expert system only, which includes a stage-matched manual, and a series of 3 individualized tailored feedback reports at baseline, 1, and 3 months.
|
Behavioral: Expert System Only
Expert system which includes a stage-matched manual, and a series of 3 individualized tailored feedback reports at baseline, 1, and 3 months
|
2: Experimental
The intervention consists of 3 components:
|
Behavioral: Enhanced Expert System
The intervention consists of 3 components:
|
The objective of the study is to document and systematically investigate the use of smoking reduction and cessation strategies targeting Chinese American smokers at various level of readiness to quit smoking.
Using a randomized controlled study design, the experimental intervention will be compared to a control group that will receive the expert system intervention only at 3-, 6- and 12-month follow-up. The primary aim is to test the following hypotheses:
The secondary aim is to examine the feasibility of the proposed intervention which will be assessed by recruitment efficiency, refusal rates, adherence, usage, safety data, and perceived helpfulness of the intervention components. In addition, analyses will be pursued to explore both short- and long-term maintenance of smoking reduction achieved, the association between smoking reduction and changes in self-efficacy of resisting from smoking, stage movements (changes in readiness for quitting), and the use of coping strategies for smoking at follow-ups. The study will provide important empirical data for developing effective smoking cessation strategies that are culturally and linguistically appropriate for the Chinese American population.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Janice Tsoh, PhD | 415-502-8438 | jtsoh@lppi.ucsf.edu |
United States, California | |||||
UCSF Langley Porter | Recruiting | ||||
San Francisco, California, United States, 94143 | |||||
Principal Investigator: Janice Tsoh, PhD |
University of California, San Francisco |
University of California Tobacco Related Disease Research Program |
Principal Investigator: | Janice Tsoh, PhD | University of California, San Francisco |
smoking reduction and cessation interventions for Chinese smokers 
  |
Responsible Party: | University of California San Francisco ( Janice Tsoh, PhD ) |
Study ID Numbers: | 14RT-0160H, TRDRP grant: 14RT-0160H, H10315-27252-03B |
First Received: | July 9, 2008 |
Last Updated: | July 9, 2008 |
ClinicalTrials.gov Identifier: | NCT00714532 |
Health Authority: | United States: Institutional Review Board |
|
|
|
|